Rilzabrutinib Plus Low-Dose Steroid Fails Pemphigus Trial ...Middle East

Medscape - News
Rilzabrutinib did not meet primary or secondary endpoints in the phase 3 PEGASUS trial of patients with pemphigus vulgaris or foliaceus. Medscape Medical News

Hence then, the article about rilzabrutinib plus low dose steroid fails pemphigus trial was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Rilzabrutinib Plus Low-Dose Steroid Fails Pemphigus Trial )

Apple Storegoogle play

Last updated :

Also on site :